KALYNN SALCEDO: Open Payments
NPI 1124527288 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$606 in 35 payments from 20 companies in 2025. Trend: 2023 $1,108 · 2024 $744 · 2025 $606
Food & beverage: $606
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $85 |
| BETA BIONICS, INC. | 4 | $49 |
| Amgen Inc. | 3 | $45 |
| SANOFI-AVENTIS U.S. LLC | 2 | $41 |
| Soleno Therapeutics, Inc. | 2 | $40 |
| Lilly USA, LLC | 2 | $36 |
| Echosens North America, Inc. | 3 | $35 |
| Medtronic, Inc. | 1 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $32 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $31 |
Products named: iLet Bionic Pancreas, TZIELD, VYKAT XR, MOUNJARO, Fibroscan, MINIMED 780G, Kerendia, ISTURISA.
Industry payments across NE — which companies pay providers there.
